References
Key articles
Cruz-Jentoft AJ, Bahat G, Bauer J, et al; Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019 Jan 1;48(1):16-31.Full text Abstract
Dent E, Morley JE, Cruz-Jentoft AJ, et al. International clinical practice guidelines for sarcopenia (ICFSR): screening, diagnosis and management. J Nutr Health Aging. 2018;22(10):1148-61. Abstract
Bhasin S, Travison TG, Manini TM, et al. Sarcopenia definition: the position statements of the Sarcopenia Definition and Outcomes Consortium. J Am Geriatr Soc. 2020 Jul;68(7):1410-8. Abstract
Chen LK, Woo J, Assantachai P, et al. Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020 Mar;21(3):300-7. Abstract
Izquierdo M, Merchant RA, Morley JE, et al. International exercise recommendations in older adults (ICFSR): expert consensus guidelines. J Nutr Health Aging. 2021;25(7):824-53.Full text Abstract
Studenski SA, Peters KW, Alley DE, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 2014 May;69(5):547-58.Full text Abstract
Reference articles
1. Cruz-Jentoft AJ, Bahat G, Bauer J, et al; Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019 Jan 1;48(1):16-31.Full text Abstract
2. Dent E, Morley JE, Cruz-Jentoft AJ, et al. International clinical practice guidelines for sarcopenia (ICFSR): screening, diagnosis and management. J Nutr Health Aging. 2018;22(10):1148-61. Abstract
3. Bhasin S, Travison TG, Manini TM, et al. Sarcopenia definition: the position statements of the Sarcopenia Definition and Outcomes Consortium. J Am Geriatr Soc. 2020 Jul;68(7):1410-8. Abstract
4. Iannuzzi-Sucich M, Prestwood KM, Kenny AM. Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women. J Gerontol A Biol Sci Med Sci. 2002 Dec;57(12):M772-7.Full text Abstract
5. Castillo EM, Goodman-Gruen D, Kritz-Silverstein D, et al. Sarcopenia in elderly men and women: the Rancho Bernardo study. Am J Prev Med. 2003 Oct;25(3):226-31. Abstract
6. Chen LK, Woo J, Assantachai P, et al. Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020 Mar;21(3):300-7. Abstract
7. Ethgen O, Beaudart C, Buckinx F, et al. The future prevalence of sarcopenia in Europe: a claim for public health action. Calcif Tissue Int. 2017 Mar;100(3):229-34.Full text Abstract
8. Petermann-Rocha F, Balntzi V, Gray SR, et al. Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2022 Feb;13(1):86-99.Full text Abstract
9. Izquierdo M, Merchant RA, Morley JE, et al. International exercise recommendations in older adults (ICFSR): expert consensus guidelines. J Nutr Health Aging. 2021;25(7):824-53.Full text Abstract
10. Global recommendations on physical activity for health. Geneva: World Health Organization; 2010.Full text Abstract
11. Bauer J, Biolo G, Cederholm T, et al. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. J Am Med Dir Assoc. 2013 Aug;14(8):542-59.Full text Abstract
12. Martone AM, Marzetti E, Calvani R, et al. Exercise and protein intake: a synergistic approach against sarcopenia. Biomed Res Int. 2017;2017:2672435.Full text Abstract
13. Lloyd BD, Williamson DA, Singh NA, et al. Recurrent and injurious falls in the year following hip fracture: a prospective study of incidence and risk factors from the Sarcopenia and Hip Fracture study. J Gerontol A Biol Sci Med Sci. 2009 May;64(5):599-609.Full text Abstract
14. Steffl M, Bohannon RW, Petr M, et al. Relation between cigarette smoking and sarcopenia: meta-analysis. Physiol Res. 2015;64(3):419-26.Full text Abstract
15. Pacifico J, Geerlings MAJ, Reijnierse EM, et al. Prevalence of sarcopenia as a comorbid disease: a systematic review and meta-analysis. Exp Gerontol. 2020 Mar;131:110801.Full text Abstract
16. Cawthon PM, Visser M, Arai H, et al. Defining terms commonly used in sarcopenia research: a glossary proposed by the Global Leadership in Sarcopenia (GLIS) Steering Committee. Eur Geriatr Med. 2022 Dec;13(6):1239-44.Full text Abstract
17. Evans WJ, Campbell WW. Sarcopenia and age-related changes in body composition and functional capacity. J Nutr. 1993 Feb;123(2 Suppl):465-8. Abstract
18. Marty E, Liu Y, Samuel A, et al. A review of sarcopenia: enhancing awareness of an increasingly prevalent disease. Bone. 2017 Dec;105:276-86. Abstract
19. Cannataro R, Carbone L, Petro JL, et al. Sarcopenia: etiology, nutritional approaches, and miRNAs. Int J Mol Sci. 2021 Sep 8;22(18):9724.Full text Abstract
20. World Health Organization. A healthy lifestyle - WHO recommendations. May 2010 [internet publication].Full text
21. World Health Organization. The Asia-Pacific perspective: redefining obesity and its treatment. Feb 2000 [internet publication].Full text
22. Chalermsri C, Aekplakorn W, Srinonprasert V. Body mass index combined with possible sarcopenia status is better than BMI or possible sarcopenia status alone for predicting all-cause mortality among Asian community-dwelling older adults. Front Nutr. 2022 Jun 30;9:881121.Full text Abstract
23. Kortebein P, Symons TB, Ferrando A, et al. Functional impact of 10 days of bed rest in healthy older adults. J Gerontol A Biol Sci Med Sci. 2008 Oct;63(10):1076-81.Full text Abstract
24. DeMik DE, Marinier MC, Glass NA, et al. Prevalence of sarcopenia and sarcopenic obesity in an academic total joint arthroplasty practice. Arthroplast Today. 2022 Jun 4;16:124-9.Full text Abstract
25. Dent E, Morley JE, Cruz-Jentoft AJ, et al. Physical frailty: ICFSR international clinical practice guidelines for identification and management. J Nutr Health Aging. 2019;23(9):771-87.Full text Abstract
26. Malmstrom TK, Miller DK, Simonsick EM, et al. SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopenia Muscle. 2016 Mar;7(1):28-36.Full text Abstract
27. Kirk B, Zanker J, Bani Hassan E, et al. Sarcopenia Definitions and Outcomes Consortium (SDOC) criteria are strongly associated with malnutrition, depression, falls, and fractures in high-risk older persons. J Am Med Dir Assoc. 2021 Apr;22(4):741-5. Abstract
29. Li M, Kong Y, Chen H, et al Accuracy and prognostic ability of the SARC-F questionnaire and Ishii's score in the screening of sarcopenia in geriatric inpatients. Braz J Med Biol Res. 2019;52(9):e8204.Full text Abstract
30. Bahat G, Erdoğan T, İlhan B. SARC-F and other screening tests for sarcopenia. Curr Opin Clin Nutr Metab Care. 2022 Jan 1;25(1):37-42. Abstract
31. Ishii S, Tanaka T, Shibasaki K, et al. Development of a simple screening test for sarcopenia in older adults. Geriatr Gerontol Int. 2014 Feb;14(suppl 1):93-101.Full text Abstract
32. Holmgren M, Lindgren A, de Munter J, et al. Impacts of mobility disability and high and increasing body mass index on health-related quality of life and participation in society: a population-based cohort study from Sweden. BMC Public Health. 2014 Apr 17;14:381.Full text Abstract
33. Baumgartner RN, Wayne SJ, Waters DL, et al. Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obes Res. 2004 Dec;12(12):1995-2004.Full text Abstract
34. Barazzoni R, Bischoff S, Boirie Y, et al. Sarcopenic obesity: time to meet the challenge. Obes Facts. 2018 Jul 18;11(4):294-305.Full text Abstract
35. Dodds RM, Syddall HE, Cooper R, et al. Grip strength across the life course: normative data from twelve British studies. PLoS One. 2014 Dec 4;9(12):e113637.Full text Abstract
36. Wu SW, Wu SF, Liang HW, et al. Measuring factors affecting grip strength in a Taiwan Chinese population and a comparison with consolidated norms. Appl Ergon. 2009 Jul;40(4):811-5. Abstract
37. Tanimoto Y, Watanabe M, Sun W, et al. Association between sarcopenia and higher-level functional capacity in daily living in community-dwelling elderly subjects in Japan. Arch Gerontol Geriatr. 2012 Sep-Oct;55(2):e9-13. Abstract
38. Jones CJ, Rikli RE, Beam WC. A 30-s chair-stand test as a measure of lower body strength in community-residing older adults. Res Q Exerc Sport. 1999 Jun;70(2):113-9. Abstract
39. Miller ME, Magaziner J, Marsh AP, et al; LIFE Investigators. Gait speed and mobility disability: revisiting meaningful levels in diverse clinical populations. J Am Geriatr Soc. 2018 May;66(5):954-61.Full text Abstract
40. Studenski SA, Peters KW, Alley DE, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 2014 May;69(5):547-58.Full text Abstract
41. Beaudart C, McCloskey E, Bruyère O, et al. Sarcopenia in daily practice: assessment and management. BMC Geriatr. 2016 Oct 5;16(1):170.Full text Abstract
42. Phu S, Kirk B, Bani Hassan E, et al. The diagnostic value of the Short Physical Performance Battery for sarcopenia. BMC Geriatr. 2020 Jul 13;20(1):242.Full text Abstract
43. Podsiadlo D, Richardson S. The timed "Up & Go": a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991 Feb;39(2):142-8. Abstract
44. Rolland YM, Cesari M, Miller ME, et al. Reliability of the 400-m usual-pace walk test as an assessment of mobility limitation in older adults. J Am Geriatr Soc. 2004 Jun;52(6):972-6. Abstract
45. Huber FA, Del Grande F, Rizzo S, et l. MRI in the assessment of adipose tissues and muscle composition: how to use it. Quant Imaging Med Surg. 2020 Aug;10(8):1636-49.Full text Abstract
46. Janssen I, Heymsfield SB, Wang ZM, et al. Skeletal muscle mass and distribution in 468 men and women aged 18-88 yr. J Appl Physiol (1985). 2000 Jul;89(1):81-8.Full text Abstract
47. Laskey MA. Dual-energy X-ray absorptiometry and body composition. Nutrition. 1996 Jan;12(1):45-51. Abstract
48. Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998 Apr 15;147(8):755-63.Full text Abstract
49. Kyle UG, Genton L, Hans D, et al. Age-related differences in fat-free mass, skeletal muscle, body cell mass and fat mass between 18 and 94 years. Eur J Clin Nutr. 2001 Aug;55(8):663-72. Abstract
50. Khalil SF, Mohktar MS, Ibrahim F. The theory and fundamentals of bioimpedance analysis in clinical status monitoring and diagnosis of diseases. Sensors (Basel). 2014 Jun 19;14(6):10895-928.Full text Abstract
51. Verghese J, Wang C, Xue X, et al. Self-reported difficulty in climbing up or down stairs in nondisabled elderly. Arch Phys Med Rehabil. 2008 Jan;89(1):100-4.Full text Abstract
52. Skelton DA, Greig CA, Davies JM, et al. Strength, power and related functional ability of healthy people aged 65-89 years. Age Ageing. 1994 Sep;23(5):371-7. Abstract
53. Evans WJ, Morley JE, Argilés J, et al. Cachexia: a new definition. Clin Nutr. 2008 Dec;27(6):793-9. Abstract
54. Zanker J, Sim M, Anderson K, et al. Consensus guidelines for sarcopenia prevention, diagnosis and management in Australia and New Zealand. J Cachexia Sarcopenia Muscle. 2023 Feb;14(1):142-56.Full text Abstract
55. Kirk B, Zanker J, Duque G. Osteosarcopenia: epidemiology, diagnosis, and treatment-facts and numbers. J Cachexia Sarcopenia Muscle. 2020 Jun;11(3):609-18.Full text Abstract
56. Pedersen BK, Saltin B. Exercise as medicine - evidence for prescribing exercise as therapy in 26 different chronic diseases. Scand J Med Sci Sports. 2015 Dec;25(suppl 3):1-72.Full text Abstract
57. Cruz-Jentoft AJ, Landi F, Schneider SM, et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing. 2014 Nov;43(6):748-59.Full text Abstract
58. Yoshimura Y, Wakabayashi H, Yamada M, et al. Interventions for treating sarcopenia: a systematic review and meta-analysis of randomized controlled studies. J Am Med Dir Assoc. 2017 Jun 1;18(6):553.e1-16. Abstract
59. Johnston AP, De Lisio M, Parise G. Resistance training, sarcopenia, and the mitochondrial theory of aging. Appl Physiol Nutr Metab. 2008 Feb;33(1):191-9. Abstract
60. Rooks D, Swan T, Goswami B, et al. Bimagrumab vs optimized standard of care for treatment of sarcopenia in community-dwelling older adults: a randomized clinical trial. JAMA Netw Open. 2020 Oct 1;3(10):e2020836.Full text Abstract
61. Morley JE. Pharmacologic options for the treatment of sarcopenia. Calcif Tissue Int. 2016 Apr;98(4):319-33. Abstract
62. Ferreira LF, Scariot EL, da Rosa LHT. The effect of different exercise programs on sarcopenia criteria in older people: a systematic review of systematic reviews with meta-analysis. Arch Gerontol Geriatr. 2023 Feb;105:104868. Abstract
63. Peterson MD, Gordon PM. Resistance exercise for the aging adult: clinical implications and prescription guidelines. Am J Med. 2011 Mar;124(3):194-8. Abstract
64. Peterson MD, Rhea MR, Sen A, et al. Resistance exercise for muscular strength in older adults: a meta-analysis. Ageing Res Rev. 2010 Jul;9(3):226-37.Full text Abstract
65. Raymond MJ, Bramley-Tzerefos RE, Jeffs KJ, et al. Systematic review of high-intensity progressive resistance strength training of the lower limb compared with other intensities of strength training in older adults. Arch Phys Med Rehabil. 2013 Aug;94(8):1458-72. Abstract
66. Fatouros IG, Kambas A, Katrabasas I, et al. Strength training and detraining effects on muscular strength, anaerobic power, and mobility of inactive older men are intensity dependent. Br J Sports Med. 2005 Oct;39(10):776-80.Full text Abstract
67. Kalapotharakos VI, Michalopoulou M, Godolias G, Tokmakidis SP, Malliou PV, Gourgoulis V. The effects of high- and moderate-resistance training on muscle function in the elderly. J Aging Phys Act. 2004 Apr;12(2):131-43. Abstract
68. Seynnes O, Fiatarone Singh MA, Hue O, et al. Physiological and functional responses to low-moderate versus high-intensity progressive resistance training in frail elders. J Gerontol A Biol Sci Med Sci. 2004 May;59(5):503-9.Full text Abstract
69. Heo JW, No MH, Min DH, et al. Aging-induced sarcopenia and exercise. Asian J Kinesiol. 2017 Apr 30;19(2):43-59.Full text
70. Arai H, Wakabayashi H, Yoshimura Y, et al. Chapter 4 Treatment of sarcopenia. Geriatr Gerontol Int. 2018 May;18(suppl 1):28-44.Full text Abstract
71. Food and Agriculture Organization of the United Nations, World Health Organization (WHO), United Nations University. Protein and amino acid requirements in human nutrition: report of a joint WHO/FAO/UNU Expert Consultation. WHO technical report series no. 935. Geneva: WHO; 2007:1-265.Full text Abstract
72. Morais JA, Chevalier S, Gougeon R. Protein turnover and requirements in the healthy and frail elderly. J Nutr Health Aging. 2006 Jul-Aug;10(4):272-83. Abstract
73. Cuthbertson D, Smith K, Babraj J, et al. Anabolic signaling deficits underlie amino acid resistance of wasting, aging muscle. FASEB J. 2005 Mar;19(3):422-4.Full text Abstract
74. Paddon-Jones D, Campbell WW, Jacques PF, et al. Protein and healthy aging. Am J Clin Nutr. 2015 Jun;101(6):1339S-45S.Full text Abstract
75. Areta JL, Burke LM, Ross ML, et al. Timing and distribution of protein ingestion during prolonged recovery from resistance exercise alters myofibrillar protein synthesis. J Physiol. 2013 May 1;591(9):2319-31.Full text Abstract
76. Morton RW, Murphy KT, McKellar SR, et al. A systematic review, meta-analysis and meta-regression of the effect of protein supplementation on resistance training-induced gains in muscle mass and strength in healthy adults. Br J Sports Med. 2018 Mar;52(6):376-84. [Erratum in: Br J Sports Med. 2020 Oct;54(19):e7.]Full text Abstract
77. Mifflin MD, St Jeor ST, Hill LA, et al. A new predictive equation for resting energy expenditure in healthy individuals. Am J Clin Nutr. 1990 Feb;51(2):241-7. Abstract
78. Matta J, Mayo N, Dionne IJ, et al. Interrelated factors favoring physical performance and activity in older adults from the NuAge cohort study. Exp Gerontol. 2014 Jul;55:37-43. Abstract
79. Chiu HL, Yeh TT, Lo YT, et al. The effects of the Otago Exercise Programme on actual and perceived balance in older adults: a meta-analysis. PLoS One. 2021 Aug 6;16(8):e0255780.Full text Abstract
80. Schwenk M, Bergquist R, Boulton E, et al. The adapted lifestyle-integrated functional exercise program for preventing functional decline in young seniors: development and initial evaluation. Gerontology. 2019;65(4):362-74.Full text Abstract
81. Erlich AT, Tryon LD, Crilly MJ, et al. Function of specialized regulatory proteins and signaling pathways in exercise-induced muscle mitochondrial biogenesis. Integr Med Res. 2016 Sep;5(3):187-97.Full text Abstract
82. Konopka AR, Harber MP. Skeletal muscle hypertrophy after aerobic exercise training. Exerc Sport Sci Rev. 2014 Apr;42(2):53-61.Full text Abstract
83. Seo DY, Lee SR, Kim N, et al. Age-related changes in skeletal muscle mitochondria: the role of exercise. Integr Med Res. 2016 Sep;5(3):182-6.Full text Abstract
84. Harber MP, Konopka AR, Undem MK, et al. Aerobic exercise training induces skeletal muscle hypertrophy and age-dependent adaptations in myofiber function in young and older men. J Appl Physiol (1985). 2012 Nov;113(9):1495-504.Full text Abstract
85. McPhee JS, French DP, Jackson D, et al. Physical activity in older age: perspectives for healthy ageing and frailty. Biogerontology. 2016 Jun;17(3):567-80.Full text Abstract
86. Glasser CE, Gartner MR, Wilson D, et al. Locally acting ACE-083 increases muscle volume in healthy volunteers. Muscle Nerve. 2018 Jun;57(6):921-6.Full text Abstract
87. Becker C, Lord SR, Studenski SA, et al; STEADY Group. Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial. Lancet Diabetes Endocrinol. 2015 Dec;3(12):948-57. Abstract
88. Rooks D, Praestgaard J, Hariry S, et al. Treatment of sarcopenia with bimagrumab: results from a phase II, randomized, controlled, proof-of-concept study. J Am Geriatr Soc. 2017 Sep;65(9):1988-95. Abstract
89. McGlory C, Calder PC, Nunes EA. The influence of omega-3 fatty acids on skeletal muscle protein turnover in health, disuse, and disease. Front Nutr. 2019 Sep 6;6:144.Full text Abstract
90. De Bandt JP. Leucine and mammalian target of rapamycin-dependent activation of muscle protein synthesis in aging. J Nutr. 2016 Dec;146(12):2616S-624S.Full text Abstract
91. Martínez-Arnau FM, Fonfría-Vivas R, Cauli O. Beneficial effects of leucine supplementation on criteria for sarcopenia: a systematic review. Nutrients. 2019 Oct 17;11(10):2504.Full text Abstract
92. Van Koevering M, Nissen S. Oxidation of leucine and alpha-ketoisocaproate to beta-hydroxy-beta-methylbutyrate in vivo. Am J Physiol. 1992 Jan;262(1 Pt 1):E27-31. Abstract
93. Smith HJ, Wyke SM, Tisdale MJ. Mechanism of the attenuation of proteolysis-inducing factor stimulated protein degradation in muscle by beta-hydroxy-beta-methylbutyrate. Cancer Res. 2004 Dec 1;64(23):8731-5.Full text Abstract
94. Jakubowski JS, Wong EPT, Nunes EA, et al. Equivalent hypertrophy and strength gains in beta-hydroxy-beta-methylbutyrate- or leucine-supplemented men. Med Sci Sports Exerc. 2019 Jan;51(1):65-74.Full text Abstract
95. Berton L, Bano G, Carraro S, et al. Effect of oral beta-hydroxy-beta-methylbutyrate (HMB) supplementation on physical performance in healthy old women over 65 years: an open label randomized controlled trial. PLoS One. 2015 Nov 3;10(11):e0141757.Full text Abstract
96. Courel-Ibáñez J, Vetrovsky T, Dadova K, et al. Health benefits of beta-hydroxy-beta-methylbutyrate (HMB) supplementation in addition to physical exercise in older adults: a systematic review with meta-analysis. Nutrients. 2019 Sep 3;11(9):2082.Full text Abstract
97. World Health Organization. WHO guidelines on physical activity and sedentary behaviour. Nov 2020 [internet publication].Full text
98. Xu J, Wan CS, Ktoris K, et al. Sarcopenia is associated with mortality in adults: a systematic review and meta-analysis. Gerontology. 2022;68(4):361-76.Full text Abstract
99. Zhang X, Zhang W, Wang C, et al. Sarcopenia as a predictor of hospitalization among older people: a systematic review and meta-analysis. BMC Geriatr. 2018 Aug 22;18(1):188.Full text Abstract
100. Beaudart C, Rizzoli R, Bruyère O, et al. Sarcopenia: burden and challenges for public health. Arch Public Health. 2014 Dec 18;72(1):45.Full text Abstract
101. Montero-Odasso M, van der Velde N, Martin FC, et al; Task Force on Global Guidelines for Falls in Older Adults. World guidelines for falls prevention and management for older adults: a global initiative. Age Ageing. 2022 Sep 2;51(9):afac205.Full text Abstract
102. Miller TJ, Sheckter CC, Barnes LA, et al. Sarcopenia is a risk factor for infection for patients undergoing abdominoperineal resection and flap-based reconstruction. Plast Reconstr Surg Glob Open. 2019 Jul 26;7(7):e2343.Full text Abstract
103. Prado CM, Baracos VE, McCargar LJ, et al. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res. 2009 Apr 15;15(8):2920-6.Full text Abstract
104. Miller MD, Crotty M, Giles LC, et al. Corrected arm muscle area: an independent predictor of long-term mortality in community-dwelling older adults? J Am Geriatr Soc. 2002 Jul;50(7):1272-7. Abstract
105. Fahlman MM, Topp R, McNevin N, et al. Structured exercise in older adults with limited functional ability: assessing the benefits of an aerobic plus resistance training program. J Gerontol Nurs. 2007 Jun;33(6):32-9. Abstract
Use of this content is subject to our disclaimer